AbbVie Stock Will $300: Timing and Risks to Watch
AbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Understand the key aspects of points and cash back rewards. Equip yourself with knowledge to maximize your benefits.
28,655 articlesAbbVie’s Q1 2026 results show strong immunology growth even as biosimilar challenges weigh on revenue. Analysts debat...
Global markets slide as tech shares drop on fading AI chip optimism. Analysts warn the downturn could spill into broa...
A surge in OpenClaw adoption, punctuated by thousands lining up outside Tencent, signals a new era for China's AI sec...
The U.K. moves to bar under-16s from major platforms, setting up a widening policy shift that could reshape families’...
Michigan lawmakers weigh Gov. Whitmer's housing package, drawing on Austin's reforms as a potential road map. Advocat...
The FDA approved bemotrizinol for over-the-counter sunscreen use on June 9, 2026, introducing the first new ingredien...
A landmark New Mexico case accuses Meta of downplaying safety risks for children on Instagram, Facebook, and WhatsApp...
A new poll in 2026 finds a rising minority of Gen Z workers would prefer a robot supervisor, challenging traditional ...
Santa Clara County filed a landmark lawsuit against Meta, accusing the company of profiting from scam advertisements ...
As housing markets tighten, brokerages race to deploy must-have real estate marketing tools in 2026. This story break...
A new Goldman Sachs study argues physical infrastructure and skilled labor will cap AI expansion even as demand for a...
A government-backed AI initiative is building a data backbone to test nutrition-focused ideas in farming. Early pilot...